PROBUCOL IN HYPERCHOLESTEROLEMIA - A DOUBLE-BLIND-STUDY

被引：38

作者：

RIESEN, WF ^{[1
]}

KELLER, M ^{[1
]}

MORDASINI, R ^{[1
]}

机构：

[1] UNIV BERN,TIEFENAU HOSP,LIPID RES LAB,CH-3004 BERN,SWITZERLAND

来源：

ATHEROSCLEROSIS | 1980年 / 36卷 / 02期

关键词：

D O I：

10.1016/0021-9150(80)90229-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：201 / 207

页数：7

共 20 条

[1] OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL [J].

BARNHART, JW ;

RYTTER, DJ ;

MOLELLO, JA .

LIPIDS, 1977, 12 (01) :29-33

[2]

BROWN HB, 1974, CLIN PHARMACOL THER, V16, P44

[3]

DAYTON S, 1968, LANCET, V2, P1296

[4]

DAYTON S, 1969, CIRCULATION S2, V39

[5] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].

GORDON, T ;

CASTELLI, WP ;

HJORTLAND, MC ;

KANNEL, WB ;

DAWBER, TR .

AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714

[6] DRUG-TREATMENT OF PRIMARY HYPERLIPOPROTEINEMIA [J].

KLOSE, G ;

MORDASINI, R ;

MIDDELHOFF, G ;

AUGUSTIN, J ;

GRETEN, H .

KLINISCHE WOCHENSCHRIFT, 1978, 56 (03) :99-110

[7]

KORLIN JB, 1976, J LIPID RES, V17, P30

[8]

MIETTINEN T, 1979, SEP ANN M EUR ATH GR

[9]

MIETTINEN TA, 1975, POSTGRAD MED J, V51, P71

[10]

MILLER GJ, 1975, LANCET, V1, P16

← 1 2 →